Theo dõi
Abdelrahman Hamdi
Abdelrahman Hamdi
Lecturer of Pharmaceutical Organic Chemistry, Mansoura University, Egypt
Email được xác minh tại mans.edu.eg
Tiêu đề
Trích dẫn bởi
Trích dẫn bởi
Năm
Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies
DIA Othman, A Hamdi, SS Tawfik, AA Elgazar, AS Mostafa
Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2166037, 2023
432023
New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study
MM Al-Sanea, A Hamdi, AAB Mohamed, HW El-Shafey, M Moustafa, ...
Journal of enzyme inhibition and medicinal chemistry 38 (1), 2166036, 2023
322023
Design, synthesis, antitumor, and VEGFR-2 inhibition activities of novel 4-anilino-2-vinyl-quinazolines: Molecular modeling studies
A Hamdi, HW El-Shafey, DIA Othman, AS El-Azab, NA AlSaif, AM Alaa
Bioorganic Chemistry 122, 105710, 2022
252022
Synthesis, antitumor, and apoptosis-inducing activities of novel 5-arylidenethiazolidine-2, 4-dione derivatives: histone deacetylases inhibitory activity and molecular docking …
A Hamdi, WM Elhusseiny, DIA Othman, A Haikal, AH Bakheit, AS El-Azab, ...
European Journal of Medicinal Chemistry 244, 114827, 2022
232022
Novel 2-arylthiazolidin-4-one-thiazole hybrids with potent activity against Mycobacterium tuberculosis
DIA Othman, A Hamdi, MM Abdel-Aziz, SM Elfeky
Bioorganic Chemistry 124, 105809, 2022
222022
Development of new thiazolidine-2, 4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: Design, synthesis, biological investigations, and in …
A Hamdi, M Yaseen, WA Ewes, MA Bhat, NI Ziedan, HW El-Shafey, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2231170, 2023
192023
Novel quinazolin-2-yl 1, 2, 3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study
NFM El Hamaky, A Hamdi, WA Bayoumi, AA Elgazar, MNA Nasr
Bioorganic Chemistry 148, 107437, 2024
132024
Design, synthesis, and biological investigation of oxadiazolyl, thiadiazolyl, and pyrimidinyl linked antipyrine derivatives as potential non-acidic anti-inflammatory agents
MM Al-Sanea, A Hamdi, S Brogi, S S. Tawfik, DIA Othman, M Elshal, ...
Journal of enzyme inhibition and medicinal chemistry 38 (1), 2162511, 2023
132023
Anti-inflammatory effect of 3-fluorophenyl pyrimidinylimidazo [2, 1-b] thiazole derivatives as p38α inhibitors
MM Al-Sanea, MS Abdel-Maksoud, MF El-Behairy, A Hamdi, HU Rahman, ...
Bioorganic Chemistry 139, 106716, 2023
132023
Combination of ligand and structure based virtual screening approaches for the discovery of potential PARP1 inhibitors
MM Al-Sanea, G Chilingaryan, N Abelyan, M Mamikonyan, H Gasparyan, ...
PLoS One 17 (9), e0272065, 2022
122022
Unraveling the nephroprotective potential of papaverine against cisplatin toxicity through mitigating oxidative stress and inflammation: insights from in silico, in vitro, and …
SA Abass, AA Elgazar, SS El-Kholy, AI El-Refaiy, RA Nawaya, MA Bhat, ...
Molecules 29 (9), 1927, 2024
112024
Acetylene-free synthesis of vinyloxy pyridine and quinoline
A Hamdi, AS Mostafa, CN Watat, MY Laurent, KB Ayed, KB Selim, ...
Tetrahedron Letters 57 (51), 5825-5829, 2016
102016
Synthesis and in vivo antifibrotic activity of novel leflunomide analogues
A Hamdi, E Said, A A Farahat, S AA El-Bialy, M AM Massoud
Letters in Drug Design & Discovery 13 (9), 912-920, 2016
92016
Synthesis of novel spirochromane incorporating Schiff's bases, potential antiproliferative activity, and dual EGFR/HER2 inhibition: Cell cycle analysis and in silico study
DIA Othman, A Hamdi, WM Elhusseiny, AS El-Azab, AH Bakheit, ...
Saudi Pharmaceutical Journal 31 (11), 101803, 2023
82023
Identification of benzothiazoles bearing 1, 3, 4-thiadiazole as antiproliferative hybrids targeting VEGFR-2 and BRAF kinase: design, synthesis, BIO evaluation and in silico study
WA Ewes, SS Tawfik, AM Almatary, M Ahmad Bhat, HW El-Shafey, ...
Molecules 29 (13), 3186, 2024
62024
S-Alkylated quinazolin-4 (3 H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study
SS Tawfik, A Hamdi, AR Ali, AA Elgazar, HW El-Shafey, AS El-Azab, ...
RSC advances 14 (36), 26325-26339, 2024
52024
Understanding chemistry and unique NMR characters of novel amide and ester leflunomide analogues
MA Henen, A Hamdi, AA Farahat, MAM Massoud
Magnetochemistry 3 (4), 41, 2017
42017
Harnessing potential COX-2 engagement for boosting anticancer activity of substituted 2-mercapto-4 (3H)-quinazolinones with promising EGFR/VEGFR-2 inhibitory activities
A Hamdi, SS Tawfik, AR Ali, WA Ewes, A Haikal, AS El-Azab, AH Bakheit, ...
Bioorganic Chemistry 153, 107951, 2024
22024
1, 3-Dipolar cycloaddition of vinyloxy quinolines with α-alkoxy carbonyl aldonitrones or cyclic surrogates: A comparative study for an asymmetric access to trans 4-quinolinoxy …
A Hamdi, MY Laurent, A Hémon-Ribaud, AS Mostafa, MAM Massoud, ...
Tetrahedron 75 (3), 429-440, 2019
22019
Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors
MM Al-Sanea, HM Hafez, AAB Mohamed, HW El-Shafey, AA Elgazar, ...
Drug Design, Development and Therapy, 5109-5127, 2024
12024
Hệ thống không thể thực hiện thao tác ngay bây giờ. Hãy thử lại sau.
Bài viết 1–20